New government research from experts led by Sir David King, the Government’s chief scientific adviser, warns that half of all adults in the UK could be clinically obese by 2050, causing health problems on a huge scale with a steep rise in heart disease, diabetes and cancer which could stretch health service resources to the breaking point.
It is estimated that 50 to 70 million Americans chronically suffer from a disorder of sleep and wakefulness, hindering daily functioning and adversely affecting health and longevity. The cumulative long-term effects of sleep loss and sleep disorders have been associated with a wide range of deleterious health consequences including an increased risk of hypertension, diabetes, obesity, depression, heart attack, and stroke.
The anti-obesity drug rimonabant hasn’t even been approved for sale yet in the European Union, yet counterfeit versions of the drug are already being sold illegally over the internet, using the drug’s proposed brand name Accomplia. The EU Commission has warned bluntly: “Patients who buy unlicensed and counterfeit or illicit copies of rimonabant may be putting their health at risk”.
A 2-year longitudinal study shows that men and women taking the experimental weight-loss drug rimonabant lost weight and kept it off. However, specialists warn that medication use should be minimized when lifestyle changes can achieve the same purpose.
Counting calories isn’t the best way to lose weight, according to a new Brigham Young University pilot study suggesting that an approach toward food called “intuitive eating” is better than restrictive diets for producing lower cholesterol levels, body mass index scores and cardiovascular disease risk.
We comply with the HONcode standard for trustworthy health information: verify here.
